Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelic Integration and Everyday Transformation: Celebrating the Depths of Intentional Living

Psychedelics Weekly – The Power of Our Breath: A Deep Dive...

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for...

COMPASS Pathways to participate in upcoming Cantor Fitzgerald and HC Wainwright...

Ibogaine’s Surge in Popularity Could Be a Huge Loss for the...

Optimi Health To Supply MDMA For Therapist Experiential Training Program at...

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Psychedelic Bulletin #139: Kentucky Earmarks $42m for Ibogaine Studies; Reunion Announces...

Numinus Appoints New Chief Financial Officer

PT415 – Psychedelic Science 2023: The Largest Psychedelic Conference in History

1...616263...218 Page 62 of 218

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin